Johnson & Johnson (JNJ) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Johnson & Johnson (JNJ:NYSE), powered by AI.

Current Price
$235.18
P/E Ratio
21.1
Market Cap
566.3B
Sector
Healthcare
What is the Johnson & Johnson stock price forecast?

Johnson & Johnson is currently trading at $235.18. View real-time AI analysis on Alpha Lenz.

What is Johnson & Johnson insider trading activity?

View the latest insider trading data for Johnson & Johnson on Alpha Lenz.

What is Johnson & Johnson's P/E ratio?

Johnson & Johnson's P/E ratio is 21.1.

Johnson & Johnson

NYSE · JNJ
$235.18-0.48(-0.20%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Johnson & Johnson's future dividend policy...
Alpha Chat Insight

Johnson & Johnson trades at a P/E of 21.1 (fair value) with strong ROE of 35.0%. Operating margin of 27.2% indicates strong profitability.

Ask for details

Company Overview

Johnson & Johnson is a multinational corporation engaged in the research, development, production, and sale of a broad range of healthcare products. Primarily known for its pharmaceuticals, medical devices, and consumer health products, Johnson & Johnson has a significant presence in the global healthcare industry. It develops medications for a variety of fields such as immunology, oncology, neurology, infectious diseases, and vaccines. The company also produces a wide array of medical devices for surgery, orthopedics, and cardiovascular health. In addition to pharmaceuticals, Johnson & Johnson is renowned for its consumer health products, including baby care, skin and hair care, wound care, and over-the-counter pharmaceuticals, with well-recognized brands like Band-Aid, Tylenol, and Neutrogena. Operating globally, the corporation's extensive portfolio and commitment to healthcare innovation make it a pivotal player in the industry, ensuring it remains influential in addressing worldwide health challenges and advancing medical technology.

CEOMr. Joaquin Duato
SectorHealthcare
IndustryDrug Manufacturers - General
Employees138,100

Company Statistics

FY 2025

Profile

$566.30BMarket Cap
$94.19BRevenue
0.00Shares Out
138,100Employees

Margins

67.88%Gross
37.33%EBITDA
27.17%Operating
34.59%Pre-Tax
28.46%Net

Valuation

21.13P/E
6.94P/B
6.01EV/Sales
16.91EV/EBITDA
29.32P/FCF

Growth (CAGR)

5.60%Rev 3Yr
2.67%Rev 5Yr
4.84%Op Inc 3Yr
5.34%Op Inc 5Yr
14.32%Net Inc 3Yr
12.74%Net Inc 5Yr

Returns

14.13%ROA
35.03%ROE
17.69%ROIC

Financial Health

$19.71BCash & Cash Equivalents
$97.96BNet Debt
144.30%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Johnson & Johnson (ticker: JNJ) is a company listed on NYSE in the Healthcare sector (Drug Manufacturers - General). It has approximately 138,100 employees. Market cap is $566.3B.

The current price is $235.18 with a P/E ratio of 21.13x and P/B of 6.94x.

ROE is 35.03% and operating margin is 27.17%. Annual revenue is $94.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Johnson & Johnson (JNJ) Stock Forecast 2026 $235.18 — Price, Financials & Analyst Targets | Alpha Lenz